ReviewMolecular and clinical oncology2026
Tumor microenvironment-mediated resistance to immune checkpoint inhibitors in non-small cell lung cancer: Mechanisms, combination strategies and clinical perspectives (Review).
Jiange Mu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.